
Capricorn Partners seeks EUR 25m for industrial biotech VC fund
Belgian VC investor Capricorn Partners is open to more investor approaches for its new industrial biotech fund as it aims for a final close on EUR 25m by the end of next year, partner Rob van der Meij told Unquote.
The firm is targeting corporate and institutional investors keen to support sustainable industrial biotech and chemistry companies. It is looking to raise a further EUR 10m-15m for the vehicle.
The VC also welcomes investments from other funds, such as in fund-of-funds type of investment, particularly from those that seek its expertise in supporting cleantech and industrial biotech.
Capricorn Industrial Biotech Fund, which was launched earlier this month, already has EUR 10m in commitments from two investors: the Dutch regional economic development agency InnovationQuarter and Dutch industrial chemicals company DSM.
Capricorn plans to use the fund to back 17 early-stage sustainable chemistry companies that are in the midst of the energy and feedstock transition and that are based in the Benelux or Germany. It aims to create an ecosystem of sustainable industrial biotech in those regions.
The firm targets significant minority stakes with active participation on the board of companies, as well as networking and expertise support, van der Meij said. It finances seed and Series A rounds, providing initial tickets of between EUR 250,000 and EUR 500,000, and total tickets of EUR 3m per company.
It tends to invest alone in early funding rounds and as part of a syndicate in later-stage rounds. Capricorn’s holding period is between five and 10 years, and it has so far exited four companies, including German biotech firm c-LEcta, which it sold to Kerry Group earlier this year. Capricorn Partners might pursue two more exits in 2023, van der Meij noted.
Capricorn has more than EUR 118m in committed capital with a focus on areas such as cleantech, biotech, and digital technology sectors. Among its portfolio companies, UK-based developer of polyethylene film Void Technologies is currently in the midst of launching its new funding round, he said.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater